The latest international news, analysis and features on the HIV epidemic from Avert. Share your views and expertise with your peers in the comments box below the articles.
Although the risk of developing cancer is decreasing for people living with HIV as antiretroviral treatment (ART) improves, it remains higher for certain cancers – and as ART expands, this burden is expected to grow.
First update on cryptococcus in the era of antiretroviral treatment expansion reveals disproportionate burden in sub-Saharan Africa and a need for better treatment options.
The proportion of people affected by the leading cause of death for people living with HIV, tuberculosis, is on the rise in Europe.
Gay men living with HIV are 37 times more likely to develop anal cancer than HIV-negative gay men, but a lack of guidelines means these men don’t get screened.
Progress in halting TB – the world’s leading infectious disease killer – is plagued by a lack of political will and inequalities in healthcare access
Expanding access to treatment for people living with HIV is shown to decrease tuberculosis (TB) incidence – but it is not the silver bullet.
Study in South Africa and Burkina Faso shows that simple HPV screening could help save lives in places with limited health infrastructure.
Kenya becomes first country in the world to introduce child-friendly tuberculosis (TB) medicine. It is hoped that the roll-out of this medication will drastically reduce the number of child TB deaths in the country.
Cryptococcal meningitis (crypto) may not be the first thing that comes to mind when talking about HIV – but this common opportunistic infection and AIDS-defining illness is one of the leading killers of people living with HIV globally.